Table II.
Clinical variables for adult patients with COVID-19, n = 100
| Oxygen saturation on room air in ED | 91% (88%, 94%) |
| Respiratory support on admission | |
| None required | 18 (18) |
| Nasal cannula | 56 (56) |
| Non-rebreather mask | 22 (22) |
| Intubated immediately | 4 (4) |
| Maximum respiratory support | |
| None required | 12 (12) |
| Nasal cannula | 46 (46) |
| Non-rebreather mask | 26 (26) |
| High-flow nasal cannula | 3 (3) |
| Mechanical ventilation | 13 (13) |
| Age-adjusted Charlson comorbidity index∗ | |
| 0 | 66 (66) |
| 1 | 23 (23) |
| 2 | 5 (5) |
| 3 | 4 (4) |
| 4 | 2 (2) |
| Number of comorbidities, including obesity, lung disease, cardiac disease, diabetes, or hypertension | |
| 0 | 31 (31) |
| 1 | 25 (25) |
| 2 | 26 (26) |
| 3 | 10 (10) |
| 4 | 8 (8) |
| History of lung disease | 19 (19) |
| History of cardiac disease | 9 (9) |
| History of diabetes | 26 (26) |
| History of obesity | 48 (48) |
| History of hypertension | 37 (37) |
| Maximum C-reactive protein, mg/dL | 14.6 (8.5, 23.2) |
| Need for dialysis | 5 (5) |
| Intubated on unit | 13 (13) |
Values are median (IQR) or n (%).
Age-adjusted Charlson comorbidity index.7